Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Anzeneder

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Deutsches Arzteblatt International|September 18, 2015
The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-upElke Peters, Tobias Anzeneder, Christian Jackisch, et al.
Nature Communications|July 18, 2023
Cancer-associated fibroblast classification in single-cell and spatial proteomics dataLena Cords, Sandra Tietscher, Tobias Anzeneder, et al.
Nature Communications|January 7, 2023
A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancerSandra Tietscher, Johanna Wagner, Tobias Anzeneder, et al.
Scientific Reports|September 3, 2020
Compared DNA and RNA quality of breast cancer biobanking samples after long-term storage protocols in - 80 °C and liquid nitrogenMaximilian Babel, Andreas Mamilos, Stephan Seitz, et al.
BMC Cancer|July 17, 2019
Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapyMark Laible, Kerstin Hartmann, Claudia Gürtler, et al.
Advances in Radiation Oncology|October 30, 2018
Superficial radiation therapy in peyronie's disease: An effective and well-tolerated therapyGunilla Pietsch, Tobias Anzeneder, Harald Bruckbauer, et al.
Breast Cancer Research : BCR|January 17, 2013
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screeningVera Kloten, Birte Becker, Kirsten Winner, et al.
BMC Cancer|August 13, 2016
AKT1 (E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detectionMarion Rudolph, Tobias Anzeneder, Anke Schulz, et al.
Plos One|April 16, 2015
AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detectionStefan Garczyk, Saskia von Stillfried, Wiebke Antonopoulos, et al.
Cancer Research|February 4, 2015
Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancerVerena Thewes, Ronald Simon, Petra Schroeter, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Deutsches Arzteblatt International|September 18, 2015
The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-upElke Peters, Tobias Anzeneder, Christian Jackisch, et al.
Nature Communications|July 18, 2023
Cancer-associated fibroblast classification in single-cell and spatial proteomics dataLena Cords, Sandra Tietscher, Tobias Anzeneder, et al.
Nature Communications|January 7, 2023
A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancerSandra Tietscher, Johanna Wagner, Tobias Anzeneder, et al.
Scientific Reports|September 3, 2020
Compared DNA and RNA quality of breast cancer biobanking samples after long-term storage protocols in - 80 °C and liquid nitrogenMaximilian Babel, Andreas Mamilos, Stephan Seitz, et al.
BMC Cancer|July 17, 2019
Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapyMark Laible, Kerstin Hartmann, Claudia Gürtler, et al.
Advances in Radiation Oncology|October 30, 2018
Superficial radiation therapy in peyronie's disease: An effective and well-tolerated therapyGunilla Pietsch, Tobias Anzeneder, Harald Bruckbauer, et al.
Breast Cancer Research : BCR|January 17, 2013
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screeningVera Kloten, Birte Becker, Kirsten Winner, et al.
BMC Cancer|August 13, 2016
AKT1 (E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detectionMarion Rudolph, Tobias Anzeneder, Anke Schulz, et al.
Plos One|April 16, 2015
AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detectionStefan Garczyk, Saskia von Stillfried, Wiebke Antonopoulos, et al.
Cancer Research|February 4, 2015
Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancerVerena Thewes, Ronald Simon, Petra Schroeter, et al.
Pageof 2